The Study of AZD8529 for Smoking Cessation in Female Smokers

NCT02401022 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

214

Enrollment

NIH

Sponsor class

Conditions

Tobacco Use Disorder

Interventions

DRUG: AZD8529

Sponsor

National Institute on Drug Abuse (NIDA)